Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 81

1.

The president speaks: prevention is best: lessons from protecting the ozone layer.

Woodcock A.

Thorax. 2012 Dec;67(12):1028-31. doi: 10.1136/thoraxjnl-2012-202628. Epub 2012 Sep 27.

PMID:
23019254
2.

Economics of "essential use exemptions" for metered-dose inhalers under the Montreal Protocol.

DeCanio SJ, Norman CS.

J Environ Manage. 2007 Oct;85(1):1-8. Epub 2006 Sep 18.

PMID:
16982135
3.

Switching to CFC-free beclometasone for asthma.

[No authors listed]

Drug Ther Bull. 2008 Jun;46(6):46-8. doi: 10.1136/dtb.2008.05.0013.

PMID:
18525059
4.

The Montreal Protocol and essential use exemptions.

D'Souza S.

J Aerosol Med. 1995 Spring;8 Suppl 1:S13-7.

PMID:
10150490
5.

New delivery systems and propellants.

Dolovich M.

Can Respir J. 1999 May-Jun;6(3):290-5. Review.

PMID:
10393290
6.

Switching to CFC-free inhalers.

Weller T.

Prof Nurse. 1999 Nov;15(2):73. No abstract available.

PMID:
10765307
7.

The role of international environmental agreements in metered-dose inhaler technology changes.

Forte R Jr, Dibble C.

J Allergy Clin Immunol. 1999 Dec;104(6):S217-20.

PMID:
10588977
8.

Stratospheric ozone, global warming, and the principle of unintended consequences--an ongoing science and policy success story.

Andersen SO, Halberstadt ML, Borgford-Parnell N.

J Air Waste Manag Assoc. 2013 Jun;63(6):607-47. Review.

PMID:
23858990
9.

CFC Phase-Out and the Chiesi Solution.

Huchon G, Fabbri LM.

Respiration. 2005;72 Suppl 1:1-2. No abstract available.

PMID:
15915005
10.

The change to non-CFC metered dose inhalers.

Rubinfeld A.

Aust Fam Physician. 1997 Dec;26(12):1412-4.

PMID:
9470296
11.
12.

Transition to CFC-free metered dose inhalers--into the new millennium.

McDonald KJ, Martin GP.

Int J Pharm. 2000 May 15;201(1):89-107. Review.

PMID:
10867268
13.

[Changes in metered dose inhaler propellants].

Chinet T.

Rev Mal Respir. 2000 Feb;17(1):15-20. Review. French.

PMID:
10756552
14.

The CFC to HFA transition and its impact on pulmonary drug development.

Leach CL.

Respir Care. 2005 Sep;50(9):1201-8. Review.

15.
16.
17.

Developing an in vitro understanding of patient experience with hydrofluoroalkane-metered dose inhalers.

Doub WH, Shah V, Limb S, Guo C, Liu X, Ngo D.

J Pharm Sci. 2014 Nov;103(11):3648-3656. doi: 10.1002/jps.24167. Epub 2014 Sep 16.

PMID:
25228114
18.

The ozone layer and metered dose inhalers.

Boulet LP.

Can Respir J. 1998 May-Jun;5(3):176-9.

PMID:
9707462
19.

Alcohol-based pressurised metered-dose inhalers for use in asthma: a descriptive study.

Alrasbi M, Sheikh A.

Prim Care Respir J. 2008 Jun;17(2):111-3. doi: 10.3132/pcrj.2008.00020.

20.

Continuing patient care with metered-dose inhalers.

Woodcock A.

J Aerosol Med. 1995 Summer;8 Suppl 2:S5-10.

PMID:
10155357

Supplemental Content

Support Center